These insights begin to build a profile of an archetypal patient whose feelings of low efficacy and perceived inability to live up to the standards of diabetes management cause them to seek validation in other ways, including harmful weight loss methods such as insulin restriction. The gene discussed is INS; the disease is diabetes mellitus.